Opportunities for Healthy Volunteers
Contribute to medical research by participating in studies designed for healthy participants in your selected area.
↓
Matched clinical trials
Study Comparing Sacituzumab Govitecan to Physician’s Choice Treatment for Patients with Advanced Triple-Negative Breast Cancer
Not recruiting
Investigated Diseases:Investigated Drugs:
+6
Study of Datopotamab Deruxtecan and Durvalumab for Adults with Untreated Triple-Negative or Hormone Receptor-Low/HER2-Negative Breast Cancer
Not recruiting
Investigated Diseases:Investigated Drugs:
+3
Study of Nadunolimab with Gemcitabine and Carboplatin for Patients with Advanced Triple Negative Breast Cancer
Not recruiting
Investigated Diseases:Investigated Drugs:
Study on the Effectiveness of Carboplatin and Olaparib for Patients with Triple-Negative Breast Cancer with Positive HRD Status
Not recruiting
Investigated Diseases:Investigated Drugs:
Study of JK08, Pembrolizumab, and Lenvatinib for Patients with Advanced or Metastatic Cancer
Not recruiting
Investigated Diseases:Investigated Drugs:
Study of Paclitaxel, Carboplatin, and Durvalumab with or without Oleclumab for Patients with Untreated Advanced Triple-Negative Breast Cancer
Not recruiting
Investigated Diseases:Investigated Drugs:
Study to Improve Tolerance of Sacituzumab Govitecan with Loperamide and Filgrastim in Patients with Advanced Triple-Negative or Luminal Breast Cancer
Not recruiting
Investigated Diseases:Investigated Drugs:
Study on Atezolizumab and Drug Combinations for Advanced Malignancies in Patients from Previous Atezolizumab Trials
Not recruiting
Investigated Drugs:
+5
Study on the Effects and Safety of PLX038 for Patients with Advanced or Metastatic Triple-Negative Breast Cancer
Not recruiting
Investigated Diseases:Investigated Drugs: